***********************************
Brakke Consulting’s
Animal Health News & Notes for February 18, 2022
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
2022 Industry Overview
Earnings News
Alivira Animal Health
Nestlé
Orion Animal Health
Royal DSM
Spectrum Brands
Swedencare
Trupanion
Zoetis
Other News
Bimeda
Bright Pet
Brisk Health Pets
Dog Child
Dyadic
Hound
Huvepharma
Intervacc
Jaguar Animal Health
Leap Venture Studio
Mars Petcare
Mella
PetHub
Petix
Petz
Phibro Animal Health
Shepherd Veterinary Software
Vetsie
************************************
KC ANIMAL HEALTH CORRIDOR
ANIMAL HEALTH SUMMIT
NOW ACCEPTING 2022 EMERGING COMPANY APPLICATIONS
The KC Animal Health Corridor is now accepting applications from early-stage companies to present at the 14th annual Animal Health Summit, held in Kansas City on August 29-30, 2022.
The 14th annual Summit is one of the only opportunities in the world for early-stage companies in the animal health and nutrition sectors to present their vision, business plan and technology to potential investors.
The selection committee will consider companies that meet the following criteria:
– Seeking $500,000 – $20 million in funding, or strategic partnerships to advance a company’s technology
– Revenue projections of $20 million within 5-7 years
Applications are due by April 4. To apply to present as an emerging company, visit the Animal Health Summit application page .
For more information, contact Kimberly Young at young@thinkkc.com.
*********************************************
EARNINGS NEWS RELEASES
- Zoetis reported its financial results for the full year 2021. Revenue was $7.8 billion, an increase of 16% compared with full year 2020. Net income was $2.0 billion, an increase of 24%. Revenue for the US was $4.04 billion, an increase of 14%. (company website)
- Nestlé reported full-year results for 2021. PetCare sales were CHF 15.56 billion ($16.8 billion), an increase of 11% year-over-year (organic growth of +13%). Underlying trade operating profit for the segment was CHF 3.3 billion ($3.6 billion), an increase of 6%. (company website)
- SeQuent Scientific, parent company of Alivira Animal Health, reported results for the third quarter of its fiscal year 2022. Turnover was INR3.58 billion ($47.65 million), an increase of 1%. (IHS Markit Connect)
- Orion Animal Health reported results for the full year 2021. Revenues declined 18% to EUR 73 million ($83 million). Gains from new product launches and distribution agreements were more than cancelled out by the loss of the Zoetis deal at the end of 2020. (IHS Markit Connect)
- Swedencare reported results for the full year 2021. Net revenue was 4 million ($82.7 million), an increase of 221% over 2020. Operating profit was SEK129.7 million ($13.8 million), 116% more than the previous year. (GlobalPets)
- Spectrum Brands reported results for the first quarter of fiscal year 2022 ended January 2, 2022. Global Pet Care sales were $302 million, an increase of 10% compared to the prior-year quarter. Segment adjusted EBITDA was $39 million, a decline of 28%. (company website)
- Trupanion, Inc. announced financial results for the full year ended December 31, 2021. Total revenue was $699.0 million, an increase of 39% compared to 2020. Net loss was $(35.5) million compared to net loss of $(5.8) million in 2020; adjusted EBITDA was $4.7 million, compared to $11.5 million in 2020. Total enrolled pets was 1,176,778 at December 31, 2021, an increase of 36%. (company press release)
- Royal DSM reported results for the full year 2021. Animal nutrition sales rose 16% to EUR 3.5 billion ($3.97 billion). (IHS Markit Connect)
************************************
Brakke Consulting
Announcing the 2022 Brakke Industry Overview
Presented at WVC: Monday, March 7th, 2-4 pm, Four Seasons Hotel, Acacia Ballroom
We are back to being in person! Come join us at Brakke Consulting’s annual Industry Overview presented at VMX and WVC in 2022. The Overview will feature industry and top global company performance, brand new market research from companion animal veterinarians, and a closer look at the current and future use of monoclonal antibodies in veterinary medicine.
Brand new this year – led by Brakke Senior Consultant Paul Casady, a panel of industry leaders will discuss their views on the outlook for the companion animal market, so you can hear firsthand from these experts. Panelists for WVC will include:
– Mr. Randolph Legg, President and Head of Commercial Business, Boehringer Ingelheim Animal Health USA
– Mr. Steve Shell, President, MWI Animal Health
– Mr. Greg Hartmann, Chief Executive Officer, NVA
Sign up today using this link, or email Amanda McDavid or call her at 336-396-3916. Pre-registration cost is $399; there are discounts for multiple attendees from the same company. We look forward to seeing you there!
www.BrakkeConsulting.com
*********************************************
COMPANY NEWS RELEASES
- Bimeda announced the launch of generic Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings. (Vet Advantage)
- Huvepharma announced it has received FDA approval for Tilmovet AC (generic tilmicosin phosphate), an aqueous concentrate for the control of swine respiratory disease. (Feedstuffs)
- Phibro Animal Health announced an exclusive license agreement with Dyadic to utilize Dyadic’s engineered C1-cells to produce specific targeted antigens for development and commercialization of a poultry vaccine for an unspecified disease. The parties will also continue working on additional animal vaccine candidates to be produced from Dyadic’s C1-cells. Financial terms were not disclosed. (IHS Markit Connect)
- Jaguar Animal Health has submitted a request to the FDA’s Center for Veterinary Medicine for Minor Use/Minor Species (MUMS) designation for the company’s drug candidate crofelemer (Canalevia) for treatment of exercise-induced diarrhea in dogs. The oral, plant-based drug was conditionally approved by the FDA in December 2021 for the treatment of chemotherapy-induced diarrhea in dogs. (DVM360)
- Intervacc announced it applied to the USDA for a permit to sell Strangvac – a vaccine against equine strangles – in the US. Strangvac is set to be commercialized across Europe during the first quarter of 2022. (IHS Markit Connect)
- Brisk Health Pets announced the launch of its subscription-based, on-demand mobile veterinarian concierge service that lets pet parents access a licensed veterinarian anytime via video consultations as well as in-home visits. (nevadabusiness.com)
- Six pet care startups were selected for Leap Venture Studio’s fifth cohort. Leap Ventures was created in 2017 by Kinship, a division of Mars Petcare and Michelson Found Animals. The startups joining the Leap Venture Studio portfolio are: Bright Pet (plant-based dog treats); Dog Child (online community for home-cooked pet meals); Hound (veterinary employee experience platform); Mella (connected wellness monitoring products); PetHub (data platform and subscription membership service for pet owners); and Vetsie (virtual care platform & pet owner marketplace). (Pet Product News)
- Petz, a pet retail chain in Brazil, announced it has acquired Petix, which makes premium and sustainable dog pads, and its US division, WizSmart by Petix. Petix produces premium pee pads made from repurposed baby diapers normally disposed by leading companies for minor defects. Financial terms were not disclosed. (Pet Product News)
- Shepherd Veterinary Software announced the expansion of their platform’s automation capabilities. (company press release)
***********************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- US – AVIAN INFLUENZA The USDA’s Animal and Plant Health Inspection Service (APHIS) has confirmed the presence of highly pathogenic avian influenza (HPAI) in birds in two states – a flock of commercial broiler chickens in Fulton County, Kentucky, and a backyard flock of mixed species birds in Fauquier County, Virginia. APHIS will continue to announce the first case of HPAI in commercial and backyard flocks detected in a state but will not announce subsequent detections in the state. (USDA)
- US – ANTIMICROBIALS The FDA released a request for public comments about antimicrobial use in companion animals (e.g., cats, dogs, horses) and the potential impact of this use on antimicrobial resistance in both animals and people. The FDA’s Center for Veterinary Medicine (CVM) intends to use the information collected to help develop strategies to further promote antimicrobial stewardship in companion animals. Click here for more information. (FDA)
- US – BOVINE DISEASE RESEARCH A Purdue University research team is developing a nose swab test to detect bovine respiratory disease that can be administered pen-side and can deliver results in about an hour. The test can identify three strains of bacteria that contribute to BRD: Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. (Vet Advantage)
- US – POULTRY RESEARCH USPOULTRY and the USPOULTRY Foundation announced the completion of a funded research project at Mississippi State University wherein researchers identified potential Camplylobacter jejuni vaccine candidates for poultry. The research was made possible in part by an endowing Foundation gift from Peco Foods. (Feedstuffs)
************************************
BRAKKE CONSULTING VIEWPOINT
This newsletter contains news of a worrying development for the US poultry industry; a reminder that highly pathogenic avian influenza (HPAI) has been found in commercial poultry operations in Indiana, Kentucky, and now in a backyard flock in Virginia. The last substantial outbreak of HPAI occurred in 2015, and resulted in a significant cull of chickens and turkeys in the US. The current findings of HPAI come at a time when US wholesale broiler/fryer prices as reported by the USDA / ARC are already over 50% above pricing at this same time in 2021. Let’s hope that discipline in infection control will succeed in extinguishing this outbreak among US growers. The whole animal production industry suffers when consumers are bombarded with news about health concerns in our food supply chain.
Have a great week!
Jim Kroman
***********************************
YOUR VIEW
Last week’s poll asked you to tell us about your use of the social media platform TikTok. 75% of our respondents said that they don’t use TikTok and the other 25% identified as “lurkers” – they view but don’t post. Only 1 person indicated that they post on the platform.
This week
English (United States) 
Portuguese